Source - LSE Regulatory
For immediate release 27 March 2009 FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC (the 'Company') MARKET PURCHASE OF COMPANY'S OWN SHARES Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 23 July 2008 to make market purchases of the Company's own shares up to an aggregate maximum of 6,656,521 that a market total of 115,500 Ordinary shares of 25p each in the capital of the Company were purchased today by the Company at a price of 525.81p per share. Such shares will be held as treasury shares. Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that: the total number of Ordinary shares held by the Company in treasury following the purchase is 3,058,050; and the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares held by the Company in treasury following such purchase, and therefore, the total number of voting rights in the Company is 41,361,431. The figure of 41,361,431 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. For and on behalf of Frostrow Capital LLP Company Secretary For further information, please contact: Mark Pope Frostrow Capital LLP Tel: 020 3 0084913 END
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.